ClinicalTrials.Veeva

Menu

IntellaTip MiFi XP Ablation Catheter Trial (MiFi-CTI)

Boston Scientific logo

Boston Scientific

Status

Completed

Conditions

Atrial Flutter

Treatments

Device: IntellaTip MiFi XP Catheter

Study type

Interventional

Funder types

Industry

Identifiers

NCT01730807
MiFi-CTI

Details and patient eligibility

About

A study to assess the performance of a new catheter design for the treatment of Atrial Flutter.

Full description

A prospective, non-blinded, single arm, single center study designed to assess the performance of the IntellaTip MiFi XP Ablation Catheter for the treatment of recurrent or sustained type I atrial Flutter.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 or older
  • indicated for ablation for Atrial Flutter

Exclusion criteria

  • Thrombus
  • Recent MI/cardiac revascularization
  • Prosthetic Valves
  • recent ablation for atrial flutter
  • atrial flutter with reversible cause
  • Class IV HF

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

IntellaTip XP MiFi
Experimental group
Description:
Patients with Atrial Flutter will receive ablation treatment with the IntellaTip MiFi XP catheter
Treatment:
Device: IntellaTip MiFi XP Catheter

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems